LIMN
NASDAQ
$0.11
Liminatus Pharma Inc (LIMN)
Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California.
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$5.14M
Beta (5Y)
0.19
Price Chart
Valuation
Market Cap$5.14M
Profitability
EBITDA-$4.42M
EPS-$0.42
Financial Health
Debt-to-Equity-1087.9%
Growth & Risk
Beta (5Y)0.19
Sharpe Ratio-1.23